Emigut Oral Solution

Ondansetron Indications Emigut is a serotonin subtype 3 (5-HT3) receptor antagonist indicated: Description Emigut oral soluble film is a orally dissolving film designed to be applied on top of the tongue where it will dissolve within 20 seconds and then is swallowed with saliva. Oral soluble film does not require water to aid dissolution or […]

Emigut Tablet

Ondansetron Indications Emigut is a serotonin subtype 3 (5-HT3) receptor antagonist indicated: Description Emigut oral soluble film is a orally dissolving film designed to be applied on top of the tongue where it will dissolve within 20 seconds and then is swallowed with saliva. Oral soluble film does not require water to aid dissolution or […]

Duomeal Oral Suspension

Aluminium Hydroxide + Magnesium Hydroxide Indications Aluminium Hydroxide and Magnesium Hydroxide is indicated for Hyperacidity, peptic ulcer, gastritis, heartburn, sour stomach & dyspepsia. Composition Each tablet contains- Each 5 ml contains- Pharmacology This drug is well-balanced combination of essential non-systemic antacids which excel in efficacy and palatability. These are dependable antacid preparations without acid rebound, […]

D-Met Tablet

Metformin Hydrochloride Indications Treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control. A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure. Pharmacology Metformin is a biguanide […]

Conatrim Cream

Econazole Nitrate + Triamcinolone Acetonide Indications Econazole Nitrate & Triamcinolone Acetonide indicated for the treatment of: Onychomycoses- for the treatment of onychomycoses, local therapy with Econazole/Triamcinolone cream, combined with an oral antimycotic, is recommended. Description This cream is a broad spectrum antimycotic with anti-inflammatory, anti-pruritic and anti-allergic effects. This cream is composed of Econazole Nitrate, […]

Combomin Tablet

Vitamin B1, B6 & B12 Indications Vitamin B1, B6 & B12 tablets is indicated where a deficiency of the relevant vitamins exists. It is indicated for the treatment of following diseases: Polyneuropathy of any origin such alcoholic or toxiconeuropathies as-diabetic, Neuritis, Neuralgia, Cervical Syndrome, Shoulder-arm syndrome, Lumbago, Sciatica, Myalgia, Intercostal neuralgia, Herpes Zoster, Trigeminal Neuralgia, […]

Co-Clav Powder for Suspension

Amoxicillin + Clavulanic Acid Indications Co-amoxiclav is indicated for short-term treatment of bacterial infections at the following sites: Composition Pharmacology Pharmacodynamic properties: Co-amoxiclav is an antibacterial combination consisting of the antibiotic Amoxicillin and the (3-lactamase inhibitor Clavulanic Acid. Amoxicillin has a broad spectrum of bactericidal activity against many Gram-positive & Gram-negative microorganisms but it is […]

Co-Clav Tablet

Amoxicillin + Clavulanic Acid Indications Co-amoxiclav is indicated for short-term treatment of bacterial infections at the following sites: Composition Pharmacology Pharmacodynamic properties: Co-amoxiclav is an antibacterial combination consisting of the antibiotic Amoxicillin and the (3-lactamase inhibitor Clavulanic Acid. Amoxicillin has a broad spectrum of bactericidal activity against many Gram-positive & Gram-negative microorganisms but it is […]

Clogrel Plus Tablet

Clopidogrel + Aspirin Indications Acute Coronary Syndrome (ACS): It is indicated to reduce the rate of Myocardial Infarction (MI) and Stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation Myocardial Infarction (NSTEMI)] and acute ST-segment elevation ACS [ST-elevation Myocardial Infarction (STEMI)]. Recent MI, recent Stroke, or established Peripheral Arterial Disease: In patients with established […]

Clogrel Tablet

Clopidogrel Bisulphate Indications Acute Coronary Syndrome (ACS): It is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI). Recent MI, recent […]